Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilizing Continuous Ketone Monitors to Enable Safe Use of SGLT Inhibitors in Patients With Type 1 Diabetes

NCT07211802 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT07211802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07211802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilizing Continuous Ketone Monitors to Enable Safe Use of SGLT Inhibitors in Patients With Type 1 Diabetes
Lead sponsor
University of California, San Diego
Phase
Phase 3
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
December 31, 2030
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes (t1d)